1. 1550PPilot study of anxiety, depression, and quality of life in patients with the diagnosis of metastatic uveal melanoma. (23rd October 2018) Authors: Nshimiyimana, R; Guzzetta, C E; Brown, M-M; Zhou, Q; Johnson, J M; Sato, T; Keith, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 230POlaparib maintenance therapy in patients (pts) with a BRCA1 and/or BRCA2 mutation (BRCAm) and newly diagnosed advanced ovarian cancer (OC): SOLO1 China cohort. (24th November 2019) Authors: Wu, L; Zhu, J; Yin, R; Wu, X; Lou, G; Wang, J; Gao, Y; Kong, B; Lu, X; Zhou, Q; Wang, Y; Chen, Y; Lu, W; Li, W; Cheng, Y; Liu, J; Ma, X; Zhang, J Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 296 Frequency of intraoperative consultation for upper abdominal primary debulking surgery in advanced ovarian cancer. (18th September 2019) Authors: Cowan, R; Tseng, J; Dearie, HF; Zhou, Q; Iasonos, A; Long Roche, K; Zivanovic, O; Gardner, G; Sonoda, Y; Chi, D Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 3 Page Start: A123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 31 Surgical cytoreduction in advanced stage serous endometrial carcinoma. (18th September 2019) Authors: Pedra Nobre, S; Zhou, Q; Iasonos, A; Chi, D; Makker, V; Abu-Rustum, N; Leitao, M; Mueller, J Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 3 Page Start: A18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 357 GLS-010 (Zimberelimab), a novel fully human anti-PD-1 mAb in chinese patients with recurrent/metastatic cervical cancer: results from a multicenter, open-label, single-arm phase II trial. (13th November 2020) Authors: Wu, X; Xia, L; Zhou, Q; Zhu, J; Wang, K; Chen, J; Huang, Y; Kurb, G; Chang, B; Zhao, W; Wang, X; Yang, Y; Lin, Z; Luo, X; Lou, G; Wang, C; Wang, J; Meng, H Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 369OBiomarker-integrated study of single agent targeting molecular alterations of PI3KCA, MET, ALK, ROS1, KRAS, NRAS or BRAF in advanced NSCLC: Phase 2 umbrella trial in China (CTONG1505). (25th November 2018) Authors: Zhou, Q; Zhang, X-C; Tu, H-Y; Gan, B; Wang, B-C; Xu, C-R; Chen, H-J; Zheng, M-Y; Wang, Z; Bai, X-Y; Sun, Y-L; Myers, A; Lv, X; Chakrabcorti, Y; Zhao, S; Yang, J-J; Wu, Y-L Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 36 Outcomes of incidentally detected ovarian cancers diagnosed at time of risk-reducing salpingo-oophorectomy in brca mutation carriers. (18th September 2019) Authors: Cowan, R; Pedra Nobre, S; Zhou, Q; Iasonos, A; Long Roche, K; Gardner, G; Abu-Rustum, N; Aghajanian, C; Cadoo, K Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 3 Page Start: A22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 38 Phase II study of enzalutamide in androgen receptor positive (AR+) recurrent ovarian cancer: final results. (18th September 2019) Authors: Grisham, R; Giri, D; Henson, M; Iasonos, A; Zhou, Q; McDonnell, A; Girshman, J; O'Cearbhaill, R; Zamarin, D; Aghajanian, C Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 3 Page Start: A23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 397OAdolescents and young adults with cancer care in Asia: The joint ESMO/SIOPE/SIOP ASIA survey. (25th November 2018) Authors: Dalvi, R; Li, C-K; Yonemori, K; Ariffin, H; Lyu, C J; Farid, M; Gonzales-Santos, J R N; Zhou, Q; Bielack, S; Brugieres, L; Blondeel, A; Essiaf, S; Peccatori, F A; Jezdic, S; Stark, D; Douillard, J-Y; Saloustros, E; Mountzios, G Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 44PPrognostic value of Ki-67 in patients with triple-negative breast cancer receiving neo-adjuvant or adjuvant chemotherapy: A systematic review and meta-analysis. (13th May 2019) Authors: Zhou, Q; Li, W Journal: Annals of oncology Issue: Volume 30(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗